echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Lancet Rheumatology: A new treatment for systemic sclerosis?

    Lancet Rheumatology: A new treatment for systemic sclerosis?

    • Last Update: 2022-03-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Systemic sclerosis remains a life-threatening autoimmune disease


    Systemic sclerosis remains a life-threatening autoimmune disease


    Society of Rheumatology and European Anti-rheumatic Immunosuppressive Therapy Autologous Hematopoietic Stem Cell Transplantation 6 6

    Between March 24, 2014, and January 6, 2020, 20 cisgender individuals (13 women and 7 men) with severe diffuse systemic sclerosis were recruited


    There were 203 infusion-related adverse events; one patient experienced grade 1 flushing, and another patient experienced grade 1 nausea and grade 2 fatigue


    Source: Dominique Farge, Séverine Loisel, et.




    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.